Published in Lancet on July 23, 1994
Patients' prerogatives and perceptions of benefit. BMJ (1996) 1.67
Risks and benefits of coronary angioplasty: the patients perspective: a preliminary study. Qual Health Care (1997) 0.93
Context of consent. Lancet (1994) 0.75
Context of consent. Lancet (1994) 0.75
Context of consent. Lancet (1994) 0.75
Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04
Surgical research or comic opera: questions, but few answers. Lancet (1996) 9.52
Using evidence to inform health policy: case study. BMJ (2001) 7.99
Sponsorship, authorship, and accountability. Lancet (2001) 7.10
Sponsorship, authorship, and accountability. N Engl J Med (2001) 6.20
Sponsorship, authorship and accountability. CMAJ (2001) 5.86
Global information flow. BMJ (2000) 5.09
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Time to register randomised trials. The case is now unanswerable. BMJ (1999) 4.55
Time to redefine authorship. BMJ (1996) 4.39
The rhetoric of research. BMJ (1995) 4.20
A manifesto for reading medicine. Lancet (1997) 3.83
Health and peace: time for a new discipline. Lancet (2001) 3.52
Spinning the risks and benefits of calcium antagonists. Lancet (1995) 3.43
Confusion as New England Journal editor is forced out. Lancet (1999) 3.32
Learning from stories--The Lancet's case reports. Lancet (1995) 3.19
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol (1997) 3.07
Conflicts of interest in clinical research: opprobrium or obsession? Lancet (1997) 3.06
Medical editors trial amnesty. Lancet (1997) 3.00
A physician's life. Lancet (1996) 2.93
Lies, damn lies, and reports of RCTs. Lancet (1996) 2.90
Women as women with HIV. Lancet (1995) 2.70
Sponsorship, authorship, and accountability. Ann Intern Med (2001) 2.66
Lancet electronic research archive in international health and eprint server. Lancet (1999) 2.53
The MHC haplotype project: a resource for HLA-linked association studies. Tissue Antigens (2002) 2.16
Mbeki defiant about South African HIV/AIDS strategy. Lancet (2000) 2.16
The 12th World AIDS Conference: a cautionary tale. Lancet (1998) 2.10
Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest (1966) 2.01
Ruling out Ingelfinger? Lancet (1996) 1.84
A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques. J Clin Endocrinol Metab (1972) 1.77
Science of sudden cardiac death. Lancet (1994) 1.76
Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab (1979) 1.75
Steroid prehormones. Perspect Biol Med (1968) 1.73
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Pardonable revisions and protocol reviews. Lancet (1997) 1.64
The Academy stumbles, then advances under fire. Lancet (1996) 1.63
Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest (1969) 1.56
Myths in medicine. Jenner did not discover vaccination. BMJ (1995) 1.53
Metabolism of prostaglandins A1 and E1 in man. J Clin Invest (1975) 1.50
[Registration of clinical trials: a statement from the International Committee of Medical Journal Editors]. Ned Tijdschr Geneeskd (2004) 1.45
The signature of responsibility. Lancet (1997) 1.44
Laser palliation of malignant dysphagia. Lancet (1993) 1.43
Male pseudohermaphroditism due to testicular 17 -hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab (1973) 1.42
New data challenge OPV theory of AIDS origin. Lancet (2000) 1.40
nvCJD: after the hype, some real data. Lancet (1997) 1.38
Revising the research record. Lancet (1995) 1.38
The realpolitik of a new National Health Service for the UK. Lancet (1998) 1.38
"...on the brink of humanitarian disaster". Lancet (1994) 1.38
Steroid dynamics under steady-state conditions. Recent Prog Horm Res (1969) 1.33
Cigarette smoking inhibits prostacyclin formation. Lancet (1983) 1.31
Having electronic preprints is logical. BMJ (1998) 1.30
Data-proof practice. Lancet (1994) 1.29
Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet (2001) 1.28
In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man. J Clin Endocrinol Metab (1967) 1.24
Sponsorship, authorship, and accountability. JAMA (2001) 1.22
The grammar of interpretive medicine. CMAJ (1998) 1.21
The infected metropolis. Lancet (1996) 1.15
Global information flow. Lancet (2000) 1.14
Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax (2009) 1.13
Sponsorship, authorship, and a tale of two media. Lancet (1997) 1.11
Fast-track to publication in the Lancet. Lancet (1997) 1.10
Role of extra- and intracellular calcium and calmodulin in renin release from rat kidney. Endocrinology (1985) 1.09
A global agenda for AIDS. Lancet (1993) 1.07
Medical student selection. J R Soc Med (1990) 1.07
A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease. J Clin Endocrinol Metab (1996) 1.06
Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome. N Engl J Med (1967) 1.06
Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol (1991) 1.06
Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism. J Clin Invest (1969) 1.05
Diagnosis and localization in primary aldosteronism. Ann Intern Med (1972) 1.05
Research for health. Lancet (1993) 1.05
The source of plasma dihydrotestosterone in man. J Clin Invest (1971) 1.05
Studies of testosterone binding globulin. J Clin Endocrinol Metab (1968) 1.05
Attacks on heart diseases. Lancet (1993) 1.04
Characterization of preferential flow in undisturbed, structured soil columns using a vertical TDR probe. J Contam Hydrol (2001) 1.03
Altered blood androgens in elderly men with prostate hyperplasia. J Clin Endocrinol Metab (1975) 1.02
Characterization of clustered MHC-linked olfactory receptor genes in human and mouse. Genome Res (2001) 1.02
Measuring recovery after a hip fracture using the SF-36 and Cummings scales. Osteoporos Int (2002) 1.01
Androstenedione and testosterone in ovarian venous and peripheral plasma during ovariectomy for breast cancer. J Clin Endocrinol Metab (1966) 1.00
The relationship between plasma renin and aldosterone in normal man. Circ Res (1970) 0.98
Research misconduct: Britain's failure to act. BMJ (2000) 0.98
Gene organisation, sequence variation and isochore structure at the centromeric boundary of the human MHC. J Mol Biol (1999) 0.98
MAST-I: agreeing to disagree. Multicentre Acute Stroke Trial--Italy Group. Lancet (1995) 0.97
Dihydrotestosterone in human peripheral plasma. J Clin Endocrinol Metab (1970) 0.97
Studies of renin and aldosterone in cirrhotic patients with ascites. Gastroenterology (1975) 0.96
Androstenedione and its conversion to plasma testosterone in congenital adrenal hyperplasia. J Clin Invest (1967) 0.95
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg (1998) 0.95
Estimation of androstenedione in human peripheral blood with 35S-thiosemicarbazide. J Clin Endocrinol Metab (1965) 0.95
Doctors, the General Medical Council, and Bristol. Lancet (1998) 0.95
A specific radioimmunossay for testosterone in peripheral plasma. J Lab Clin Med (1973) 0.95
Tissue production of androgens in women with acne. J Am Acad Dermatol (1985) 0.94
Hirsutism and virilization. Calif Med (1967) 0.93
Temocillin concentrations in human tissues. Drugs (1985) 0.93
A rapid method for the estimation of testosterone in male plasma. Steroids (1967) 0.93
Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab (1981) 0.93
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril (1985) 0.93
Are global guidelines desirable, feasible and necessary? Nat Clin Pract Gastroenterol Hepatol (2007) 0.93
Genetically modified food: consternation, confusion, and crack-up. Med J Aust (2000) 0.93
Retraction: interferon alfa-2b...in Behçet's disease. Lancet (2000) 0.92
Transforming growth factor-beta is a renin secretagogue at picomolar concentrations. Am J Physiol (1993) 0.92
Parallel radioimmunoassay for plasma cortisol and 11-deoxycortisol. Clin Chem (1975) 0.91